Clinical trial
A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma
NCT00343564 · Cytokinetics, Industry · Completed
Key facts
| NCT number | NCT00343564 |
|---|---|
| Title | A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma |
| Official title | A Phase I-II Study to Determine the Safety, Pharmacokinetics and Potential Efficacy of Intravenous Administration of SB-743921 on Days 1 and 15 of a 28-Day Dosing Schedule in Patients With Non-Hodgkin Lymphoma and Hodgkin Lymphoma |
| Lead sponsor | Cytokinetics, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma, Hodgkin's Disease |
| Intervention type | Drug |
| Interventions | SB-743921 |
| Enrollment | 68 |
| Start date | Apr 1, 2006 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Jun 23, 2006 |
| Last update posted | Jan 13, 2020 |
| Countries | Russia, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: